Vertex (VRTX) PT Raised to $300 at Wolfe Research
- Nasdaq outperforms on Alphabet boost, payrolls data in focus
- Stocks could be in 'panic' mode in 2024, warns JPM's Kolanovic
- Can S&P 500 rally without the Magnificent 7 leading the way? 'Easy' says BofA
- Analysts remain cautious on Chewy as shares drop 10% weak guidance
- AI sentiment toward Google seen improving rapidly after Gemini launch; Shares gain
Wolfe Research analyst Andrew Galler raised the price target on Vertex (NASDAQ: VRTX) to $300.00 (from $282.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Vertex Pharma (VRTX) Appoints Nancy Thornberry to its Board of Directors
- Kia Motors (000270:KS) (KIMTF) PT Raised to KRW130,000 at JPMorgan
- Mitsubishi Estate Co., Ltd. (8802:JP) (MITEY) PT Raised to JPY2,000 at JPMorgan
Create E-mail Alert Related CategoriesAnalyst PT Change
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!